-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on Avadel Pharmaceuticals, Raises Price Target to $22.5

Benzinga·11/20/2025 15:42:31
Listen to the news
Wells Fargo analyst Benjamin Burnett maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Equal-Weight and raises the price target from $20 to $22.5.